Double-blind cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance.

Abstract

Twenty patients with irritable bowel syndrome due to food intolerance were randomized to either oral sodium cromoglycate or placebo in a double-blind cross-over trial. The study consisted of treatment with either sodium cromoglycate or placebo for 8 weeks, followed by the cross-over treatment for 8 further weeks. Patients were allowed to eat the offending foods during the study. Eighteen patients completed the study. Analysis of patients' diary card scores showed a statistically significant difference in favour of sodium cromoglycate. There was a long carry-over effect in the active-placebo order group. Therefore oral sodium cromoglycate seems to be a useful treatment in patients with irritable bowel syndrome and proven food intolerance.

• Authors: C Lunardi, L M Bambara, D Biasi, P Cortina, P Peroli, F Nicolis, F Favari, M L Pacor
• Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (Clin Exp Allergy) Vol. 21 Issue 5 Pg. 569-72 (Sep 1991) ISSN: 0954-7894 [Print] England
• PMID: 1742648 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Cromolyn Sodium

Topics

• Administration, Oral
• Adult
• Colonic Diseases, Functional (drug therapy, etiology)
• Cromolyn Sodium (administration & dosage)
• Double-Blind Method
• Female
• Food Hypersensitivity (complications)
• Humans
• Male